Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

CORRECTED-WRAPUP 6-'We have a new weapon': Europe rolls out vaccines in bid to slay COVID

Sun, 27th Dec 2020 10:17

(Corrects source to BioNTech, not Pfizer, paragraphs 14-15)

* Goal is to offer vaccine to all adults through 2021

* 'Thank God,' says first recipient in Spain, 96

* Delays in some German cities over cooling concerns

* Urgency as new virus variants crop up

By Isla Binnie and Giselda Vagnoni

MADRID/ROME, Dec 27 (Reuters) - Europe launched a mass
COVID-19 vaccination drive on Sunday with pensioners and medics
lining up to get the first shots to see off a pandemic that has
crippled economies and claimed more than 1.7 million lives
worldwide.

"Thank God," 96-year-old Araceli Hidalgo said as she became
the first person in Spain to have a vaccine at her care home in
Guadalajara, near the capital Madrid.

"Let's see if we can make this virus go away."

In Italy, the first country in Europe to record significant
numbers of infections, 29-year-old nurse Claudia Alivernini was
one of three medical staff at the head of the queue for the shot
developed by Pfizer and BioNTech.

"It is the beginning of the end ... it was an exciting,
historic moment," she said at Rome's Spallanzani hospital.

The region of 450 million people is trying to catch up with
the United States and Britain, which have already started
vaccinations using the Pfizer shot.

The European Union is due to receive 12.5 million doses by
the end of the year, enough to vaccinate 6.25 million people
based on the two-dose regimen. The companies are scrambling to
meet global demand and aim to make 1.3 billion shots next year.

The bloc has secured contracts with a range of drugmakers
besides Pfizer, including Moderna and AstraZeneca
, for a total of more than two billion vaccine doses and
has set a goal for all adults to be inoculated during 2021.

With surveys pointing to high levels of hesitancy towards
the vaccine in countries from France to Poland, leaders of the
27-country European Union are promoting it as the best chance of
getting back to something like normal life next year.

"We have a new weapon against the virus: the vaccine. We
must stand firm, once more," tweeted French President Emmanuel
Macron, who tested positive for the coronavirus this month and
left quarantine on Christmas Eve.

"Completely painless," Greek Prime Minister Kyriakos said
after getting his vaccination in a hospital in Athens.

COOLING CONCERNS

The distribution of the shot presents tough challenges as
the vaccine uses new mRNA technology and must be stored at
ultra-low temperatures of about -70 degrees Celsius (-112°F).

In Germany, the campaign faced delays in several cities
after a temperature tracker showed that about 1,000 shots may
not have been kept cold enough during transit.

BioNtech said it was responsible for the shipment to the 25
German distribution centres and that the federal states and
local authorities were responsible for the shipment to the
vaccination centres and the mobile vaccination teams.

"This is where the variations in temperature occurred. We
are in contact with many authorities to provide advice, however
it is up to them how to proceed", a spokeswoman said.

The Pfizer shots being used in Europe were shipped from its
factory in Puurs, Belgium, in specially designed containers
filled with dry ice. They can be stored for up to six months at
Antarctic winter temperatures, or for five days at 2C to 8C, a
type of refrigeration commonly available at hospitals.

In Italy, temporary solar-powered healthcare pavilions
designed to look like five-petalled primrose flowers - a symbol
of spring - sprouted in town squares as the vaccination drive
kicked off.

Portugal has been establishing separate cold storage units
for its Atlantic archipelagos of Madeira and the Azores.

At the Santa Maria hospital in Portugal's capital Lisbon,
Pedro Pires waited for a shot with other nurses at the end of an
overnight shift.

"It has been tiring ... a lot of work," he told Reuters.

Branka Anicic, an 81-year-old resident of a care home in
Zagreb, became the first person to get a shot in Croatia. "I'm
happy I will now be able to see my great-grandchildren," she
said.

"It will change the lives of everyone in the world," said an
elderly passerby in Paris who gave her name as Anaik.

German pilot Samy Kramer celebrated the vaccination campaign
by tracing out a giant syringe in the sky. He flew 200 km (125
miles), following a syringe-shaped route that showed up on
internet site flightradar24.

'FIRST MAN ON THE MOON'

The vaccination drive is all the more urgent because of the
concern around new variants of the virus linked to a rapid
expansion of cases in Britain and South Africa.

"We know that the pandemic won't just disappear as of today,
but the vaccine is the beginning of the victory over the
pandemic, the vaccine is a 'game changer'. We have always know
that, and today is the first day of this new phase," Austrian
Chancellor Sebastian Kurz.

Over the past week, cases of the UK variant have been
detected in Australia, Hong Kong and in several European
countries, mostly recently Sweden, France, Norway and Portugal's
island of Madeira. So far, scientists say there is no evidence
to suggest the vaccines developed will be any less effective
against the new variants.

While Europe has some of the best-resourced healthcare
systems in the world, the sheer scale of the effort means some
countries are calling on retired medics to help while others
have loosened rules for who is allowed to give the injections.

Beyond hospitals and care homes, sports halls and convention
centres left vacant by lockdown restrictions will become venues
for mass inoculations.

Vaccinations also started in Norway, which is not a member
of the bloc but part of the EU's drive.

"I feel like a historical figure ... almost like the first
man on the Moon," said care home resident Svein Andersen, 67, as
he received the country's first shot in the capital Oslo.

After European governments were criticised for failing to
work together to counter the spread of the virus in early 2020,
the goal this time is to ensure that there is equal access to
the vaccines across the region.

But even then, Hungary on Saturday jumped the gun on the
official roll-out by administering shots to frontline workers at
hospitals in the capital Budapest. The Netherlands said it will
not start vaccinating until Jan. 8.

Slovakia also went ahead with some inoculations of
healthcare staff on Saturday and in Germany, a small number of
people at a care home were inoculated a day early too.

"We don't want to waste that one day that the vaccine loses
shelf life," Karsten Fischer, from the pandemic staff of the
Harz district in the German state of Saxony-Anhalt, told
broadcaster MDR.

(Additional reporting by Catarina Demony in Lisbon, Silke
Koltrowitz in Vienna, Robert Muller in Prague, Tsvetelia Tsolova
in Sofia, Igor Ilic in Zagreb, Nerijus Adomaitis in oslo,
Michele Kambas in Athens and Benoit Van Overstraeten in Paris;
Writing by Mark John and Andrew Heavens; Editing by David Clarke
and Nick Macfie)

More News
8 Feb 2024 08:59

LONDON MARKET OPEN: Unilever up on buyback; BAT ups dividend

(Alliance News) - THE FTSE 100 in London opened slightly higher on Thursday, with earnings from British American Tobacco and Unilever boosting the index.

Read more
8 Feb 2024 08:44

TOP NEWS: AstraZeneca confident after 2023 profit more than doubles

(Alliance News) - AstraZeneca PLC on Thursday said it expects another year of strong growth after reporting pretax profit in 2023 more than doubled.

Read more
8 Feb 2024 07:58

AstraZeneca shares slip as Q4 profits miss forecasts

(Sharecast News) - Biopharma titan AstraZeneca delivered a 6% increase in sales in 2023 despite a $3.7bn decline in Covid-19 medicines revenues, as it guided to a strong pick-up in growth this year - though profits came in slightly under analysts' forecasts.

Read more
8 Feb 2024 07:50

LONDON BRIEFING: Unilever sets new buyback; Astra profit surges

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye a busy day of earnings.

Read more
2 Feb 2024 08:38

AstraZeneca celebrates latest successful trial of acoramidis in Japan

(Alliance News) - AstraZeneca PLC on Friday said positive results from a Phase 3 trial of acoramidis are consistent with global findings, bring the drug closer to regulatory submission in Japan.

Read more
2 Feb 2024 06:22

TOP NEWS: US sends drugmakers initial offers in Medicare price talks

(Alliance News) - The US government said it was making initial offers to drugmakers Thursday as part of Medicare negotiations meant to lower the prices many older Americans would pay for 10 medicines.

Read more
1 Feb 2024 15:52

UK earnings, trading statements calendar - next 7 days

Friday 2 February 
YouGov PLCTrading Statement
Monday 5 February 
Home REIT PLCTrading Statement
Porvair PLCFull Year Results
Trident Royalties PLCTrading Statement
Vodafone Group PLCTrading Statement
Tuesday 6 February 
Alumasc Group PLCHalf Year Results
BP PLCFull Year Results
Filtronic PLCHalf Year Results
Mattioli Woods PLCHalf Year Results
Renishaw PLCHalf Year Results
Virgin Money UK PLCTrading Statement
Wednesday 7 February 
Ashmore Group PLCHalf Year Results
Barratt Developments PLCHalf Year Results
HydrogenOne Capital Growth PLCTrading Statement
Phoenix Spree Deutschland LtdTrading Statement
PZ Cussons PLCHalf Year Results
Smurfit Kappa Group PLCFull Year Results
UK Commercial Property REIT LtdTrading Statement
Thursday 8 February 
Anglo American PLCTrading Statement
AstraZeneca PLCFull Year Results
British American Tobacco PLCFull Year Results
Compass Group PLCTrading Statement
Redrow PLCHalf Year Results
SSE PLCTrading Statement
Unilever PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
29 Jan 2024 08:19

TOP NEWS: AstraZeneca, Daiichi's Enhertu granted priority review in US

(Alliance News) - AstraZeneca PLC on Monday said its cancer drug conjugate received priority review by the Food & Drug Administration in the US for patients with metastatic HER2-positive solid tumours.

Read more
22 Jan 2024 11:45

BioNTech challenges AstraZeneca with breast cancer precision drug trial

FRANKFURT, Jan 22 (Reuters) - BioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing their precision drug against a certain type of breast cancer, taking on a rival partnership between AstraZeneca and Daiichi Sankyo.

Read more
19 Jan 2024 09:28

TOP NEWS: AstraZeneca's Voydeya receives approval in Japan for PNH

(Alliance News) - AstraZeneca PLC on Friday said its inhibitor Voydeya, also known as danicopan, received approval in Japan for adults with paroxysmal nocturnal haemoglobinuria, or PNH.

Read more
16 Jan 2024 17:17

FTSE 100 hits one-month low, precious miners biggest drag

FTSE 100 down 0.5%, FTSE 250 flat

*

Read more
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.